Turn Therapeutics Ord Shs
TTRX3.370USD
-0.940-21.81%
Close 12/08, 16:00（ET）Quotes delayed by 15 min
--Market Cap
LossP/E TTM
More Details of Company
Turn Therapeutics Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Turn Therapeutics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director Nominee
Independent Director Nominee
60.60K
+100.66%
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
10.00K
+98.02%
Dr. Kent Kester
Dr. Kent Kester
Independent Director Nominee
Independent Director Nominee
10.00K
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
--
--
Mr. Bradley Burnam
Mr. Bradley Burnam
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Arthur F. Golden
Mr. Arthur F. Golden
Independent Director Nominee
Independent Director Nominee
60.60K
+100.66%
Mr. Zuraiz Chaudhary
Mr. Zuraiz Chaudhary
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Interim Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
10.00K
+98.02%
Dr. Kent Kester
Dr. Kent Kester
Independent Director Nominee
Independent Director Nominee
10.00K
--
Dr. Neilesh Shailesh (Neil) Ghodadra
Dr. Neilesh Shailesh (Neil) Ghodadra
Chief Medical Officer, Director
Chief Medical Officer, Director
--
--
Mr. Andrew Gengos
Mr. Andrew Gengos
Independent Director
Independent Director
--
--
Mr. Bradley Burnam
Mr. Bradley Burnam
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Reporting Period
No. of institutions
Shares Held
Proportion
Change
No Data
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Turn Therapeutics Ord Shs?
The top five shareholders of Turn Therapeutics Ord Shs are:
What are the top three shareholder types of Turn Therapeutics Ord Shs?
The top three shareholder types of Turn Therapeutics Ord Shs are:
Other
Other
How many institutions hold shares of Turn Therapeutics Ord Shs (TTRX)?
As of --, -- institutions hold shares of Turn Therapeutics Ord Shs, with a combined market value of approximately --, accounting for --% of the total shares. Compared to --, institutional shareholding has increased by --.
What is the biggest source of revenue for Turn Therapeutics Ord Shs?
In --, the -- business generated the highest revenue for Turn Therapeutics Ord Shs, amounting to -- and accounting for --% of total revenue.
